Showing results (151-160 of 374) with videos related to

Sort By:
Pageof 38
Pediatric Pulmonology|April 22, 2022
DNA sequencing analysis of cystic fibrosis transmembrane conductance regulator gene identifies cystic fibrosis-associated variants in the Severe Asthma Research ProgramManuel E Izquierdo, Chad R Marion, Wendy C Moore, et al.
American Journal of Respiratory and Critical Care Medicine|November 7, 2009
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research ProgramWendy C Moore, Deborah A Meyers, Sally E Wenzel, et al.
The Journal of Allergy and Clinical Immunology|December 15, 2010
Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccineWilliam W Busse, Stephen P Peters, Matthew J Fenton, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Mitochondrial DNA Copy Number Variation in Asthma Risk, Severity, and ExacerbationsWeiling Xu, Yun Soo Hong, Bo Hu, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 9, 2025
Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retrospective analysisWendy C Moore, Alexandra Stach-Klysh, Thomas Corbridge, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2002
Fine mapping of an IgE-controlling gene on chromosome 2q: Analysis of CTLA4 and CD28Timothy D Howard, Dirkje S Postma, Gregory A Hawkins, et al.
JCI Insight|April 19, 2019
The effect of BPIFA1/SPLUNC1 genetic variation on its expression and function in asthmatic airway epitheliumNiccolette Schaefer, Xingnan Li, Max A Seibold, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2024
Mitochondrial DNA copy number variation in asthma risk, severity, and exacerbationsWeiling Xu, Yun Soo Hong, Bo Hu, et al.
The Lancet. Respiratory Medicine|September 27, 2020
Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trialsChristopher E Brightling, Mina Gaga, Hiromasa Inoue, et al.
The World Allergy Organization Journal|December 30, 2022
Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness GroupEugene R Bleecker, Mona Al-Ahmad, Leif Bjermer, et al.
Pageof 38